Post-prandial increases in liver-gut hormone LEAP2 correlate with attenuated eating behaviour in adults without obesity (supplementary material) (2023)

First Author: Bhargava R

Attributed to: Human experimental medicine studies of gut hormone LEAP2, an endogenous ghrelin antagonist and target for obesity, diabetes, cachexia and addiction funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.5281/zenodo.7855554

Publication URI: https://zenodo.org/record/7855554

Type: Journal Article/Review